Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.17 USD | -1.81% | -1.36% | -6.06% |
15/05 | Compugen Names David Silberman CFO | MT |
13/05 | Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Chief Financial Officer, Effective July 12, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.06% | 89.79M | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- ORMP Stock
- News Oramed Pharmaceuticals Inc.
- Oramed Appoints Arie Mayer to its Board of Directors